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Abstract
Panton-Valentine leukocidin (PVL) is the hallmark of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) but can also
be found in methicillin-susceptible S. aureus (MSSA) sharing pathogenic and epidemiological characteristics of CA-MRSA. PVL is encoded by
two co-transcribed genes that are carried by different staphylococcal bacteriophages. We applied an extended PCR-based typing scheme for
the identiﬁcation of two morphological groups (elongated-head group and icosahedral-head group I phages) and speciﬁc PVL phage types in
S. aureus isolates recovered in Italy. We examined 48 PVL-positive isolates (25 MSSA and 23 MRSA) collected from different hospital
laboratories from April 2005 to May 2011. spa typing, multilocus sequence typing and staphylococcal cassette chromosome mec typing were
applied to categorize the isolates. Phage typeability was 48.0% in MSSA and 91.3% in MRSA, highlighting the limitation of the PCR typing
scheme when applied to PVL-positive MSSA. Five different PVL phages and two variants of a known phage were detected, the most
prevalent being ΦSa2usa, recovered in 15 out of 48 (31.2%) isolates, and carried by both MSSA and MRSA belonging to CC8 and CC5. The
recently described ΦTCH60 was recovered in four isolates. A PVL phage (ΦSa119) from an ST772 MRSA, that was not detected using the
previous typing scheme, was sequenced, and new primers were designed for the identiﬁcation of the icosahedral-head group II PVL phages
present in ST772 and ST59 MRSA. A comprehensive PVL-phage typing can contribute to the understanding of the epidemiology and
evolution of PVL-positive MSSA and MRSA.
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Introduction
Since the end of the 1990s, community-acquired methicil-
lin-resistant Staphylococcus aureus (CA-MRSA) has been rec-
ognized as a major cause of skin and soft-tissue infections
(SSTIs), and occasionally of serious invasive infections such as
necrotizing pneumonia, in young subjects without apparent
risk factors living in the community [1]. In the USA a single
CA-MRSA clone, designated USA300, is dominant, being
responsible for the majority of the SSTIs seen in emergency
departments [2]. Different CA-MRSA clones have been
detected in other areas of the world, such as ST80 in Europe
and ST30 in Oceania [3]; these clones, once apparently
geographically restricted, have now been found in different
continents, together with new emerging CA-MRSA lineages
[4]. With some exceptions, the majority of CA-MRSAs contain
the genes for the Panton-Valentine leukocidin (PVL) [5],
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a bi-component, pore-forming toxin that causes lysis of
leucocytes and subsequent tissue necrosis [6]. PVL is also
carried by some methicillin-susceptible S. aureus (MSSA)
strains, sharing similar disease potential and epidemiological
characteristics with CA-MRSA [7]. In some countries, such as
the UK, PVL-positive MSSAs are more common than MRSA in
community-acquired infections [8].
PVL is encoded by two co-transcribed genes, lukS-PV and
lukF-PV, carried by temperate phages lysogenized into S. aureus
chromosome [9]. PVL phages belong to Siphoviridae, a family
of bacteriophages characterized by double-stranded DNA,
with an icosahedral- or elongated-head morphology, and a
non-contractile tail [10]. To date, several PVL phages of the
two morphological groups have been identiﬁed and sequenced
[11–16].
In 2008, Ma et al. [15] developed a sequential PCR-based
scheme for the detection and identiﬁcation of the two
morphological groups and of the ﬁve most common PVL
phages, subsequently modiﬁed to include the PVL phage
carried by USA 300 [17].
Using this scheme, the distribution of PVL phages was
investigated in various countries. In Japan, two types of PVL
phages, Φ108PVL and ΦSa2958, were found to predominate
[15], while in England and Wales the most common phage
types were ΦPVL, ΦSa2usa and ΦSa2mw [17–19]. In China,
Φ108PVL was mostly recovered, although a speciﬁc phage type
was only identiﬁed in nine out of 58 PVL-positive isolates [20].
Following the description in emerging CA-MRSA clones of
new icosahedral-head PVL phages that escape typing by the
previous scheme, a second morphological group of icosahe-
dral-head PVL phages was identiﬁed [21,22]. Therefore, to
date, PVL phages can be classiﬁed into three groups: the
elongated-head group, icosahedral-head group I and icosahe-
dral-head group II.
In Italy, a variety of genetically distinct CA-MRSA clones are
present [23], and occurrence of PVL-positive MSSA in
community-acquired infections has been reported [24,25].
The aim of this study was to type PVL phages carried by MSSA
and MRSA isolated in Italy from community-acquired infections
to better understand the epidemiology and the evolution of
these pathogens.
Materials and Methods
Bacterial isolates
All the PVL-positive S. aureus isolates collected from April
2005 to May 2011 were examined in this study. Overall 48
PVL-positive S. aureus (25 MSSA, 52%, and 23 MRSA, 48%)
were referred on a voluntary basis by 18 hospital laboratories
located in seven different regions of north and central Italy. All
the isolates had been obtained from severe infections or
persistent or recurrent infections acquired in the community
(Table 1).
The isolates were assayed for the presence of PVL and of
mecA by PCR according to previously published methods [23].
The control isolates for phage typing were: S. aureus 81/108
(Φ108PVL), JCSC2958 (ΦSa2958), A980470 (ΦSLT), MW2
(ΦSa2mw) and USA300 FPR3757 (ΦSa2usa). As no control
was available for ΦPVL, strain SauL94 (this study) was used as a
control.
Molecular typing
Staphylococcus aureus genomic DNA was extracted with the
QIAamp DNA Mini Kit (QIAGEN, Hilden, Germany). Molec-
ular typing was performed by protein A (spa) typing and
multilocus sequence typing (MLST); the staphylococcal chro-
mosome cassette (SCC) mec was typed in MRSA isolates [23].
PVL phage detection
Phage typing was performed following the sequential scheme
of Ma et al. [15] that allows classiﬁcation of elongated-head
group and icosahedral-head group I phages. Brieﬂy, the three
steps of the scheme detected the morphological phage group,
the linkage with PVL genes and the speciﬁc phage type,
respectively. The original scheme, allowing identiﬁcation of ﬁve
phage types, was extended to include two more phage types,
ΦSa2usa [15,17] and ΦTCH60 [26] (Table 2).
If the third set of PCR assays did not identify any speciﬁc
phage type, PVL phages were identiﬁed only on the basis of the
morphological group. If the PCR assays of the scheme of Ma
yielded negative results, the presence of an unknown PVL
phage was conﬁrmed using the primers designed by Boakes
et al. [17], targeting the conserved left and right junctions of
the PVL prophage with the bacterial chromosome.
Prophage induction in strain Sau119 and electron microscopy
analysis
To detect the presence of a functional phage in strain Sau119,
mitomycin induction was performed. Brieﬂy, Sau119 was
grown in 10 mL of BHI broth at 37°C to a turbidity
corresponding to OD620 0.3. Mitomycin C (Sigma-Aldrich, St
Louis, MO, USA) was added to ﬁnal concentrations of 0.6 lg/
mL and the culture was incubated at 37°C until lysis occurred,
as shown by a decrease in turbidity. Cellular debris was
removed by centrifugation at 16 000 g for 15 min at 4°C; the
ﬁltered supernatant was ultracentrifuged at 100 000 g for 2 h
at 4°C. The pellet obtained was washed twice in PBS and
resuspended in 200 lL of PBS; this represented the phage
preparation and was stored at 80°C until used. For
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transmission electron microscopy the phage preparation was
deposited on carbon-coated copper grids, negatively stained
with 2% potassium phosphotungstate at pH 7.0 and examined
in a Philips EM 208 electron microscope.
DNA sequencing of the Sau119 phage and design of a new
typing scheme
Phage DNA was extracted from 100 lL of the phage
preparation using the QIAamp DNAMini Kit (QIAGEN). The
TABLE 1. Characteristics and PVL-phage typing of the isolates
Isolate ID Source Year ST CC MSSA/MRSA SCCmec spa type Phage morphology PVL-phage type
Sau017 Necrotizing pneumonia 2006 8 8 MRSA IV t008 Elongated-head ΦSa2usa
Sau018 Necrotizing pneumonia 2007 8 8 MRSA IV t008 Elongated-head ΦSa2usa
Sau016 SSTI 2006 8 8 MRSA IV t008 Elongated-head ΦSa2usa
Sau065 SSTI 2009 8 8 MRSA IV t008 Elongated-head ΦSa2usa
Sau116 SSTI 2010 8 8 MRSA IV t008 Elongated-head ΦSa2usa
Sau130 SSTI 2010 8 8 MRSA IV t008 Elongated-head ΦSa2usa
Sau150 SSTI 2010 8 8 MRSA IV t008 Elongated-head ΦSa2usa
Sau161 SSTI 2011 8 8 MRSA IV t008 Elongated-head ΦSa2usa
Sau164 Nasal carrier 2011 8 8 MRSA IV t008 Elongated-head ΦSa2usa
Sau085 SSTI 2010 8 8 MRSA IV t121 Elongated-head ΦSa2usa
Sau147 SSTI 2010 8 8 MSSA – t4069 Elongated-head ΦSa2usa
Sau169 Necrotizing fasciitis 2011 8 8 MSSA – t1265 Elongated-head ΦSa2usa
Sau151 SSTI 2010 1 5 MRSA V t127 Elongated-head ΦSa2usa
Sau106 Sepsis 2009 1 5 MSSA – t127 Elongated-head ΦSa2usa
Sau146 SSTI 2010 1 5 MSSA – t127 Elongated-head ΦSa2usa
Sau019 Necrotizing pneumonia 2007 80 80 MRSA IV t044 Elongated-head ΦSa2mw
Sau058 SSTI 2009 80 80 MRSA IV t044 Elongated-head ΦSa2mw
Sau089 Necrotizing fasciitis 2010 80 80 MRSA IV t044 Elongated-head ΦSa2mw
Sau149 SSTI 2010 80 80 MRSA IV t044 Elongated-head ΦSa2mw
Sau574 SSTI 2009 80 80 MRSA IV t044 Elongated-head ΦSa2mw
Sau021 Necrotizing pneumonia 2008 80 80 MRSA IV t2453 Elongated-head ΦSa2mw
Sau086 SSTI 2010 22 22 MRSA IV t005 Icosahedral-head I ΦPVL
SauL94 SSTI 2005 22 22 MSSA – t005 Icosahedral-head I ΦPVL
SauL61 Nasal carrier 2005 954 22 MSSA – t2336 Icosahedral-head I ΦPVL
SauL732 Nasal carrier 2005 956 30 MSSA – t021 Icosahedral-head I ΦPVL
Sau015 Necrotizing pneumonia 2008 30 30 MRSA IV t755 Elongated-head ΦTCH60
Sau102 SSTI 2010 30 30 MRSA IV t6955 Elongated-head ΦTCH60
Sau022 SSTI 2008 5 5 MRSA IV t319 Elongated-head ΦTCH60
Sau056 SSTI 2009 88 88 MSSA – t2310 Elongated-head ΦTCH60
Sau004 Osteomyelitis 2007 121 121 MSSA – t284 Elongated-head ΦSa2958
Sau007 SSTI 2008 1210 121 MSSA – t645 Elongated-head ΦSa2958
Sau002 Sepsis 2006 30 30 MSSA – t318 Icosahedral-head I Φ108PVL-V1a
Sau143 SSTI 2010 30 30 MSSA – t021 Icosahedral-head I Φ108PVL-V2a
Sau009 Nasal carrier 2006 1210 121 MSSA – t645 Elongated-head NT
Sau078 SSTI 2010 121 121 MSSA – t308 Elongated-head NT
Sau080 Necrotizing pneumonia 2010 121 121 MSSA – t159 Elongated-head NT
Sau114 Osteomyelitis 2010 51 121 MSSA – t159 Elongated-head NT
Sau027 SSTI 2008 88 88 MRSA V t2526 Elongated-head NT
Sau141 SSTI 2009 6 6 MSSA – t7693 Elongated-head NT
Sau037 Sepsis 2009 152 152 MSSA – t1172 Elongated-head NT
Sau136 SSTI 2010 30 30 MSSA – t318 Icosahedral-head I NT
Sau139 SSTI 2010 30 30 MSSA – t021 Icosahedral-head I NT
Sau142 SSTI 2010 1472 30 MSSA – t665 Icosahedral-head I NT
Sau001 ORL infection 2006 1209 942 MSSA – t1445 Icosahedral-head I NT
Sau008 Nasal carrier 2006 1209 942 MSSA – t1445 Icosahedral-head I NT
Sau119 SSTI 2010 772 5 MRSA V t7445 Icosahedral-head II ΦSa119
Sau005 SSTI 2008 5 5 MSSA – t1154 Unknown NT
Sau077 Necrotizing pneumonia 2010 1790 5 MSSA – t311 Unknown NT
SSTI, skin and soft tissue infection; NT, non-typeable.
aVariants of Φ108PVL (see text).
TABLE 2. PCR-based scheme for typing icosahedral-head group I and elongated-head group PVL phages
Primer use Primer (pair) name Target gene/locus Reference
I set ICOS I morphology portal-1F/portal-1R por [15]
tail-1F/tail-1R mtp [15]
ELONG morphology portal-2F/portal-2R por [15]
tail-2F/tail-2R mtp [15]
II set ICOS I-PVL linkage teil-ico-F/lukSR1 mtp, lukS-PV [15]
ELONG-PVL linkage teilE-F2/lukSR1 mtp, lukS-PV [18]
III set ΦPVL and Φ108PVL intF-2/PVL-aR/108-aR int, JP030, ant [15]
ΦSa2958 intF-2/2958-aR int, JP004 [15]
ΦSLT intF-2/SLT-aR int, ssb [15]
ΦSa2mw intF-2/MW2-aR int, cro [15]
ΦSa2usa Sa2USA_F/USA2_R2a phiSLT ORF484-like [17]
ΦTCH60 intF-2/TCH60-aR int, HMPREF0772_11656 [26]
ICOS, icosahedral-head group I; ELONG, elongated-head group.
aUSA2_R2 (50- CCTCAGCGCCATCACCAATA-30), modiﬁed from primer Sa2USA_R [17].
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nucleotide sequence was determined by applying the 454-Gen-
ome Sequencer FLX procedure (http://454.com/applications/
whole-genome-sequencing/) to libraries constructed on phage
DNA, producing >600 bp fragment reads. The draft genome
was assembled by the GS De Novo Assembler v.2.6 software
(Roche Diagnostic, Monza, Milan, Italy).
Automated gene annotation was performed by the
web-based Rapid Annotation using Subsystems Technology
(RAST) service [27]. Annotation of relevant genes was
manually curated based on annotated staphylococcal phage
genomes available in the GenBank database. The nucleotide
sequence of the PVL phage carried by Sau119 (ΦSa119) has
been deposited in GenBank under the Accession no.
KJ596420.
Blast similarity search against the nucleotide collection
database and whole-genome shotgun contigs database was
performed at the NCBI website.
On the basis of the sequence of ΦSa119, an additional typing
scheme consistent with the sequential scheme of Ma et al. [15],
allowing identiﬁcation of icosahedral-head group II PVL phages
including ΦSa119, was designed (Table 3).
Results
Molecular typing of the isolates
Molecular typing revealed the presence of 27 different spa
types, 18 among MSSA, 11 among MRSA, and two shared by
both MSSA and MRSA. Eighteen different STs were found, ﬁve
of which were shared by both MSSA and MRSA. The most
prevalent MSSA clonal groups were CC30 and CC121, each
comprising six out of 25 isolates (24.0%). The most prevalent
MRSA clonal group was CC8 (10 out of 23 isolates, 43.5%),
followed by CC80 (six out of 23 isolates, 26.0%) (Table 1).
PVL-phage typing
Applying the expanded PCR scheme of Ma, it was possible to
detect a PVL phage and determine at least the morphological
phage group (elongated-head group or icosahedral-head group
I) in 45 out of 48 isolates (93.7%). The large majority of the
PVL phages (34 out of 48, 70.8%) were elongated-head types.
A speciﬁc PVL-phage type was identiﬁed in 33 isolates (68.7%);
phage typeability was 48.0% in MSSA (12 out of 25) and 91.3%
in MRSA (21 out of 23) (Table 1).
The most common phage type was ΦSa2usa, recovered in
15 isolates (31.2%), both MRSA and MSSA belonging to CC8
and CC5 (Table 1). ΦTCH60 was recovered in four isolates
(8.3%), three MRSA belonging to CC30 and CC5 and one
MSSA belonging to CC88.
Among the icosahedral-head group I, two MSSA isolates
belonging to CC30 (Sau002 and Sau143) yielded amplicons with
primers designed to detect Φ108PVL (intF-2/108-aR, Table 2);
however, the fragments obtained were larger than expected (c.
5.6 kb instead of 4.3 kb). Sequences of the 30 end of the
amplicons were different and had identity with regions of
different PVL phages (Φ7247PVL (Genbank Accession no.
AP01195) for Sau002 phage and tp310-1 (Genbank Accession
no.NC_009761.2) for Sau143 phage). Therefore the two phages
were considered different variants of Φ108PVL and designated
Φ108PVL_V1 and Φ108PVL_V2, respectively (Table 1).
In 12 out of 48 isolates (25.0%), it was only possible to
determine the morphological phage group and not the speciﬁc
PVL-phage type.
With three isolates, including one MRSA belonging to
ST772 (Sau119), all the PCR assays of the typing scheme
yielded negative results, and accordingly the phage type was
deﬁned as unknown. In these isolates, the presence of a PVL
phage that was integrated into the same chromosomal site of
known PVL phages was conﬁrmed by PCR.
Characterization of PVL phage ΦSa119
Electron microscopy of the supernatant of a mitomy-
cin-induced culture of Sau119 revealed the presence of viral
particles consisting of a small icosahedral head and a long
ﬂexible tail that are characteristic of bacteriophages belonging
to the Siphoviridae family [28] (Fig. 1).
TABLE 3. PCR-based scheme and primers for typing icosahedral-head group II PVL phages
Primer use Primer name Sequence (50–30)
Size of PCR
product (bp) Target gene Reference
I set ICOS II morphology PORT_3 TTCGGAAGAATGATAGGTGC 535 por This study
PORT_4 TAATCCGCACCTCATTCCTTG por This study
TAIL_3 TCAAAGAATGGCAGAAAGTGG 842 mtp This study
TAIL_4 ACTCTTGGTAACTAAAGCGAC mtp This study
II set ICOS II-PVL linkage TAIL_5 AATTGGGATAGCAACGCAAGAGC 10 728 mtp This study
LukS-R1 ACGAAGTAGCAATAGGAGTGA luks-PV [15]
III set ΦSa119 (ST772 phage) intF-2 ATGTTTTCGAGTTTTTGAGTTAG 4918 int [15]
SA119Ant1 AGTATTGAATTGTCGCTACCAGC ant This study
ST59 phage intF-2 ATGTTTTCGAGTTTTTGAGTTAG 2965 int [15]
repR AGATGCTTACGTAAAGAAGG rep [21]
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Following 454 sequencing of the puriﬁed PVL phage of
Sau119, a unique contig accounting for the phage sequence
with a 300-fold coverage, was obtained by GS-FLX gsAssem-
bler software.
The phage, designated ΦSa119, was 42 600 bp in size with a
GC content of 33.4%. A 29-bp core sequence of the attP site
(50- ACCATCACATTATGATGATATAATTAGTC -30) was
identiﬁed corresponding to the 29-bp sequence found at the L
junction of the integrated phage (data not shown). The
integration site of ΦSa119 was inside a region corresponding
to the hypothetical gene with locus tag SACOL1532 in the
S. aureus COL chromosome (Genbank accession no.
CP000046).
Blast analysis of ΦSa119 sequence towards Whole Genome
Shotgun database revealed 99% identity with a region inside
genomes of ST772 isolates from India, Malaysia and Australia,
corresponding to a PVL phage named ΦIND772PVL [22]. As
observed in ΦIND772PVL and other ST772 PVL phages
[22,29], ΦSa119 contains sea, the enterotoxin A gene, located
in a region close to the PVL genes. Sequence analysis also
revealed 94% nucleotide identity between ΦSa119 and PVL
phages found in ST59 isolates, including Φ7247PVL (Genbank
accession no. AP011956) [21,30,31].
PVL phages present in both ST772 and ST59 strains belong
to the icosahedral-head group II [21,22] and are not detected
by the PCR scheme of Ma. Therefore a new scheme for PVL
phages present in both ST772 and ST59 strains of the
icosahedral-head group II was designed exploiting the identity
between the structural genes of ST772 and those of ST59 PVL
phages. For the ﬁrst set of PCR assays the morphological
group was detected by a duplex PCR targeting the structural
genes por, encoding for the portal protein, and mtp, encoding a
tail protein (Table 3). For the second set of PCR, the linkage
between the tail gene and the PVL genes was detected with a
primer pair targeting mtp and lukS. The conﬁrmatory PCR for
the ST772 phage type (third set of PCR) was developed using
primers targeting int and ant, the putative antirepressor that
appears to be speciﬁc for ΦSa119 and other ST772 phages
(Table 3). ΦSa119 was identiﬁed as an ST772 phage by this
new typing scheme, while the two MSSA isolates that carried
unknown PVL phages according to the scheme of Ma, did not
yield any positive result.
When one PVL-positive ST59 S. aureus control isolate (not
included in this study) was examined by icosahedral-head
group II typing, amplicons were obtained with primer sets 1
and 2, of the same size as those obtained with ΦSa119,
indicating that the new scheme is able to detect the PVL phage
present in ST59 at the morphological level, but no amplicon
was obtained with the PCR speciﬁc for the ST722 phage type.
A new PCR speciﬁc for the ST59 PVL-phage type was designed
using published primers targeting int and rep (Table 3). This
assay gave a positive result, allowing the identiﬁcation of the
ST59 PVL-phage type (not shown).
Discussion
This study reached a double result: a better characterization of
PVL-positive MSSA and MRSA isolates from Italy, with the
deﬁnition of the PVL phages harboured, and the expansion of
the phage typing scheme of Ma et al. [15] to include new
PVL-phage types.
In Italy, the most common PVL-positive MSSA clonal groups
recovered were CC121 and CC30, in line with the study of
Rasigade et al. [7] on a global collection of PVL-positive MSSA
clinical isolates. Among PVL-positive MRSA, the most pre-
(a)
(b)
FIG. 1. Detection of phage particles (ΦSa119) in the mitomy-
cin-induced supernatant of strain Sau119. Electron micrographs show:
(a) a single phage particle with a slightly bent tail with a morphology
typical of the Siphoviridae family; (b) a cluster of phages.
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valent lineages were CC8 and CC80, as already reported in a
previous study [23].
In this study, the original phage typing scheme of Ma has
been expanded, allowing the identiﬁcation of seven PVL
phages, including ΦSa2usa [17] and the newly detected
ΦTCH60 [26]. By the extended typing scheme, a speciﬁc
PVL-phage type could be identiﬁed in 91% of MRSA and in 48%
of MSSA. The limitation of the extended typing scheme for
MSSA could be due to the higher genetic heterogeneity of
PVL-positive MSSA in comparison with PVL-positive MRSA and
to the fact that the scheme was originally developed for MRSA
[15,17,18].
An additional typing scheme aimed at detecting PVL phages of
a new morphological group (icosahedral-head group II) present
in ST772 and ST59 clones that escapes detection by the scheme
of Ma, has been proposed. This typing scheme, which should be
applied in the case of negativity of the PCR scheme of Ma,
expands the detection of icosahedral-head phage types, allowing
identiﬁcation of the PVL-phage types present in ST772 and
ST59, clones emerging in Asia and other parts of the world
[21,22,30]. In Italy these clones are still rare; the isolate carrying
ΦSa119 was probably imported into our country, because it was
isolated from a man of Indian nationality.
This study highlights the variety of the PVL phages
recovered in a single European country: ΦSa2usa, initially
identiﬁed in the USA300 clone, was the most common, but ﬁve
other distinct PVL-phage types, including two variants of
Φ108PVL and ΦSa119 of ST772, were identiﬁed.
A lineage-speciﬁcity of PVL phages was noted in our study,
irrespective of the methicillin-resistant status of the isolates, in
line with observations previously reported [15,17–19]. The
occurrence of a single phage in a clone comprising both MSSA
and MRSA suggests that the acquisition of PVL phage is likely
to have occurred before the acquisition of SCCmec that
generated MRSA [32–34]. The recovery of ΦSa2958, previ-
ously associated with MRSA belonging to CC30, in two MSSA
belonging to CC121 is the ﬁrst report of PVL phages present in
this most prevalent lineage of PVL-positive MSSA [7].
ΦTCH60, recently identiﬁed in CC30 [26], was also detected
in CC5 and CC88 isolates.
The large variety of phages detected suggests that in Europe
and in other areas where PVL-positive MSSA and MRSA belong
to several different clones [26], the characterization of PVL
phages could be informative for the epidemiology of S. aureus
and contribute to outbreak investigation.
We have an example in our collection: MSSA strain SauL94
(ST22), carrying ΦPVL, was the epidemic strain responsible for
a prolonged community and hospital outbreak of SSTI in
northern Italy [24]. During the outbreak, many staff members
carried the PVL-positive epidemic strain but one of the
carriers was colonized by a different strain, belonging to ST30
(SauL732), that also contained ΦPVL. Because ΦPVL is
uncommon in ST30 isolates, we hypothesized that SauL732
acquired ΦPVL from the epidemic strain.
One limitation of this study is that the identiﬁcation of PVL
phages is based on PCR assays that target only a portion of the
phage genome. Because phages are prone to recombination
events, positivity by PCR should not be taken as indication of a
speciﬁc phage but rather of a type or family of PVL phages with
variable genomic portions. This occurrence has been shown in
our study when amplicons from two isolates obtained with
primers for Φ108PVL were sequenced and showed identity
with fragments of other PVL phages. Next-generation
sequencing, which is becoming increasingly available and
affordable, will generate more robust data on the diversity of
PVL phages, allowing a more comprehensive epidemiological
picture of PVL-positive S. aureus.
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